PEPconnect

Managing COVID-19–associated Coagulopathy Webinar

This presentation will describe the factors contributing to coagulopathy in COVID-19 and discuss ongoing thromboprophylaxis clinical trials in the pre-hospitalization, hospitalization, and post-hospital discharge periods to reduce thrombotic risk in COVID-19.

  • COVID-19 and Coagulopathy
  • VTE
  • Anticoagulant therapy
  • Pathophysiology
  • Thrombosis
  • Coagulopathy and COVID-19
  • covid-19 microthrombosis
  • thromboinflammation covid-19
  • thrombosis prophylaxis guidelines vte prophylaxis
  • microclots with covid
  • hypercoagulability of covid-19